Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 245 recruiting now early-phase tilt #5 of 28,963 conditions

Depression: early-phase trial registry

245 of 687 indexed Depression trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #5 of 28,963 conditions by registered trial count.

687 US clinical trials · 245 currently recruiting · #5 of 28,963 conditions by registered trial count

Depression: 687 US clinical trials tracked, 245 recruiting.

Depression is the subject of 687 registered US clinical trials on ClinicalTrials.gov, 245 of them currently open to new participants. 70 are in Phase 3-4 (later-stage) and 111 in Phase 1-2 (earlier-stage). The most active sponsor is Massachusetts General Hospital, running 29 of these trials.

Open enrollment, early-phase tilt

Depression has 687 registered US clinical trials, 245 of them open to new participants right now, about 36% of the total.

245
recruiting participants now
36%
of trials open to enrollment
70
in Phase 3-4 (later-stage)
29
top sponsor: Massachusetts General Hospital

Corpus placement: #5 of 28,963 conditions by registered trial count on ClinicalTrials.gov-derived indexes. Registry reference only, not medical advice.

Key findings

What ClinicalTrials.gov does not surface for Depression on its own pages , computed from the registry mirror as of 2026-07-11. Each line carries its own denominator so it can be quoted as it stands.

  1. Depression recruits in line with its size-band peers.

    245 of 687 indexed trials (35.7%) are open to enrollment, against a 37.2% average across 135 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Depression trials is spread across many organizations.

    Massachusetts General Hospital accounts for 29 of 687 trials (4.2%). 231 distinct sponsors appear on at least one study for this condition label.

  3. Typical Depression enrolment sits around 100 participants.

    Median target enrolment is 100 among the 680 trials that report a genuine target (sentinel values excluded). 331 of those (48.7%) plan for fewer than 100 participants.

  4. Depression research is mostly interventional.

    618 interventional and 69 observational studies make up this index (90% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 141Phase 270Phase 329Phase 441

Open and recent trials

687 total, page 7 of 14

ACTIVE NOT RECRUITING Phase 4 40 participants

Propofol-Enhanced Assessment of Ketamine for Chronic Pain and Depression

Stanford University

NCT06317636

ACTIVE NOT RECRUITING 40 participants

EEG Biomarker Study for Participants in the Neurolief "MOOD" Trial

Butler Hospital

NCT05178784

ACTIVE NOT RECRUITING NA 35 participants

Meditation Therapy in Improving Anxiety and Depression in Cancer Patients With Psychosocial Distress

M.D. Anderson Cancer Center

NCT02988271

ACTIVE NOT RECRUITING NA 30 participants

Pain Reduction Through Empowered Recovery (PRIME) Study

Johns Hopkins University

NCT05619510

ACTIVE NOT RECRUITING Phase 1 30 participants

Fixed Order, Open-Label, Dose-Escalation Study of DMT in Humans

Yale University

NCT04711915

ACTIVE NOT RECRUITING 30 participants

Using rTMS to Treat Depression

Florida International University

NCT05424224

ACTIVE NOT RECRUITING NA 26 participants

A Behavioral Activation Prenatal and Postpartum Intervention for Depressed Pregnant Smokers

M.D. Anderson Cancer Center

NCT05044546

ACTIVE NOT RECRUITING NA 25 participants

Low Intensity Focused Ultrasound: a New Paradigm for Depression and Anxiety

Ocean State Research Institute

NCT05147142

ACTIVE NOT RECRUITING NA 24 participants

An Idiographic Examination of Treatment Mechanisms in Emotion Regulation Therapy

Teachers College, Columbia University

NCT05590741

ACTIVE NOT RECRUITING NA 24 participants

Use of a Smartphone Mobile Application (App) to Enhance Smoking Cessation Treatment

M.D. Anderson Cancer Center

NCT03519451

ACTIVE NOT RECRUITING Phase 1 20 participants

Altering Default Mode Network Activity With Transcranial Focused Ultrasound to Reduce Depressive Symptoms

University of Arizona

NCT06320028

ACTIVE NOT RECRUITING NA 20 participants

Focused Ultrasound Amygdala Neuromodulation

University of Texas at Austin

NCT05228964

ACTIVE NOT RECRUITING Phase 1 17 participants

Autonomous Digital CBT Intervention for Opioid Use Disorder in Individuals With Co-Occurring Internalizing Disorders

University of Minnesota

NCT06545071

ACTIVE NOT RECRUITING NA 16 participants

A Neuroimaging Study of Open-label Placebo in Depressed Adolescents

University of California, San Francisco

NCT04201106

ACTIVE NOT RECRUITING Phase 2 15 participants

Single-dose Ketamine Treatment to Improve Depression in Mild Cognitive Impairment

Icahn School of Medicine at Mount Sinai

NCT06069843

ACTIVE NOT RECRUITING NA 15 participants

Adapting BA for Minimally Verbal Autistic Adults

Rutgers, The State University of New Jersey

NCT06064422

ACTIVE NOT RECRUITING NA 15 participants

PRISM for Depression and Anxiety in Young Adults With Cancer

Dana-Farber Cancer Institute

NCT06502483

ACTIVE NOT RECRUITING NA 14 participants

Nexalin Therapy as a Viable Adjunctive Treatment for Substance Use Disorders

University of Arizona

NCT03540745

ACTIVE NOT RECRUITING Early Phase 1 14 participants

Anxiety and Depression Levels in Cancer Patients After Self-Application of EFT (Emotional Freedom Techniques)

Soul Medicine Institute

NCT00737399

ACTIVE NOT RECRUITING Early Phase 1 10 participants

Testing a Transdiagnostic TMS Treatment Target

Brigham and Women's Hospital

NCT06282146

ACTIVE NOT RECRUITING NA 8 participants

Implementation of Collaborative Care for Depression in VA HIV Clinics

VA Office of Research and Development

NCT05901272

ACTIVE NOT RECRUITING 1 participants

Evaluation of Association Between Testosterone Levels, Dementia, and Adverse Mental Health Outcomes

M.D. Anderson Cancer Center

NCT04743466

COMPLETED NA 10,821 participants

Computerized Substance Use and Depression Screening and Behavioral Treatment in HIV Primary Care

University of California, San Francisco

NCT03217058

COMPLETED Phase 1 7,192 participants

Cooking for Health Optimization With Patients

Tulane University

NCT03443635

COMPLETED 6,894 participants

Health and Wellbeing of Pregnant and Post-Partum Women During the COVID-19 Pandemic

Pregistry

NCT04385238

COMPLETED NA 6,500 participants

Mental Health Pathways in Internet Support Groups

Carnegie Mellon University

NCT02396472

COMPLETED NA 4,370 participants

SSIs for Mental Health and Loneliness

University of California, Irvine

NCT05687162

COMPLETED 4,219 participants

Long Term Health Outcomes of Women Veterans' Service During the Vietnam Era

VA Office of Research and Development

NCT00958061

COMPLETED 4,193 participants

National Child Traumatic Stress Network (NCTSN) Quality Improvement Initiative Database

Hugo W. Moser Research Institute at Kennedy Krieger

NCT01591694

COMPLETED NA 2,562 participants

Intern Health Study 2022 and 2023

University of Michigan

NCT05436145

COMPLETED NA 2,118 participants

Providing Mental Health Precision Treatment

University of Michigan

NCT04342494

COMPLETED NA 1,800 participants

Multimedia Educational Program for Patients With Early-Stage Prostate Cancer or Breast Cancer

University of Colorado, Denver

NCT00830635

COMPLETED NA 1,765 participants

A Smartphone Intervention for Relational and Mental Well Being

University of Washington

NCT04629755

COMPLETED NA 1,485 participants

Diabetes-Depression Care-management Adoption Trial

University of Southern California

NCT01781013

COMPLETED 1,431 participants

Evaluating the Effects of Stress in Pregnancy

Emory University

NCT00525226

COMPLETED NA 1,268 participants

Development and Pilot Trial of an Intervention to Reduce Disclosure Recipients Negative Social Reactions and Victims Psychological Distress and Problem Drinking

University of New Hampshire

NCT03488927

COMPLETED NA 1,246 participants

Community Partners in Care is a Research Project Funded by the National Institutes of Health

RAND

NCT01699789

COMPLETED NA 1,114 participants

Study of a Holistic Health Program for United Methodist Clergy

Duke Clergy Health Initiative

NCT01564719

COMPLETED Phase 2 976 participants

Efficacy and Safety of Fixed Doses of BMS 820836 in the Treatment of Patients With Treatment Resistant Major Depression

Bristol-Myers Squibb

NCT01369095

COMPLETED Phase 4 971 participants

Determine The Percentage Of Depressed Outpatients Who Do Not Effectively Metabolize Extended-release Venlafaxine HCl

Wyeth is now a wholly owned subsidiary of Pfizer

NCT00788944

COMPLETED NA 925 participants

Activating Messages for Enhancing Primary Care Practice (AMEP2): Effectiveness Study

University of California, Davis

NCT01144104

COMPLETED Phase 3 876 participants

Open-Label Safety Study of AXS-05 in Subjects With Depression

Axsome Therapeutics

NCT04039022

COMPLETED NA 838 participants

Mobile Mental Health Apps for Suicide Prevention

University of Washington

NCT04536935

COMPLETED Phase 3 837 participants

Study of the Safety and Efficacy of Fixed-dose Brexpiprazole (OPC-34712) as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder With and Without Anxious Distress

Otsuka Pharmaceutical Development & Commercialization

NCT02196506

COMPLETED NA 808 participants

Enhancing Recovery After Cardiac Surgery

University of California, Los Angeles

NCT00522717

COMPLETED NA 802 participants

Collaborative Care to Reduce Depression and Increase Cancer Screening Among Low-Income Urban Women

Clinical Directors Network

NCT02273206

COMPLETED Phase 3 734 participants

Relapse-Prevention Study With Levomilnacipran ER (F2695 SR) in Patients With Major Depressive Disorder

Forest Laboratories

NCT01085812

COMPLETED 715 participants

Sleep Signal Analysis for Current Major Depressive Episode (SAMDE)

Medibio Limited

NCT05708222

COMPLETED NA 677 participants

Online Positive Emotion Skills Intervention for Symptoms of Depression

Northwestern University

NCT02861755

COMPLETED Phase 3 676 participants

Seroquel in Bipolar Depression Versus SSRI

AstraZeneca

NCT00119652

← Previous Page 7 of 14 Next →

Phase Distribution

PhaseTrial count
Phase 1 41
Phase 2 70
Phase 3 29
Phase 4 41

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What is open for Depression right now

245 recruiting of 687 indexed (36% open).

Phase mix: 70 late (III/IV) vs 111 early (I/II) (early-phase heavy).

Top sponsor: Massachusetts General Hospital (29 trials), 9 others listed. 50 shown below, recruiting first. #5 of 28,963 conditions by registered trial count.

How open-enrollment share is computed

Open share is recruiting_count divided by trial_count for this condition label in the public registry export. Status can change between pulls; treat the figure as a snapshot of research attention, not treatment availability.

Frequently Asked Questions

How many clinical trials are there for Depression?

PlainTrial tracks 687 US clinical trials for Depression, of which 245 are currently recruiting participants. Data sourced from ClinicalTrials.gov.

How do I find a recruiting trial for Depression?

Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.

Is this data current?

Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.

Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.

Verify with NIH →

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial for this condition, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.